Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1969 1
1978 1
1980 2
1987 1
1988 1
1990 1
1993 2
1999 2
2000 2
2001 2
2003 4
2004 8
2005 10
2006 9
2007 9
2008 21
2009 21
2010 8
2011 11
2012 18
2013 14
2014 19
2015 17
2016 8
2017 10
2018 13
2019 5
2020 9
2021 9
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18483377

227 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW. De Vleeschouwer S, et al. Clin Cancer Res. 2008 May 15;14(10):3098-104. doi: 10.1158/1078-0432.CCR-07-4875. Clin Cancer Res. 2008. PMID: 18483377 Free article. Clinical Trial.
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, Menten J, Clement P, Debiec-Rychter M, De Vleeschouwer S. Ardon H, et al. Cancer Immunol Immunother. 2012 Nov;61(11):2033-44. doi: 10.1007/s00262-012-1261-1. Epub 2012 Apr 22. Cancer Immunol Immunother. 2012. PMID: 22527250 Clinical Trial.
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.
De Vleeschouwer S, Ardon H, Van Calenbergh F, Sciot R, Wilms G, van Loon J, Goffin J, Van Gool S. De Vleeschouwer S, et al. Cancer Immunol Immunother. 2012 Nov;61(11):2105-12. doi: 10.1007/s00262-012-1271-z. Epub 2012 May 8. Cancer Immunol Immunother. 2012. PMID: 22565485
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M, Bercovici N, Taylor R, Vereecken P, Massicard S, Duriau D, Vernel-Pauillac F, Boyer A, Baron-Bodo V, Mallard E, Bartholeyns J, Goxe B, Latour N, Leroy S, Prigent D, Martiat P, Sales F, Laporte M, Bruyns C, Romet-Lemonne JL, Abastado JP, Lehmann F, Velu T. Salcedo M, et al. Cancer Immunol Immunother. 2006 Jul;55(7):819-29. doi: 10.1007/s00262-005-0078-6. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187085 Clinical Trial.
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
Inogés S, Tejada S, de Cerio AL, Gállego Pérez-Larraya J, Espinós J, Idoate MA, Domínguez PD, de Eulate RG, Aristu J, Bendandi M, Pastor F, Alonso M, Andreu E, Cardoso FP, Valle RD. Inogés S, et al. J Transl Med. 2017 May 12;15(1):104. doi: 10.1186/s12967-017-1202-z. J Transl Med. 2017. PMID: 28499389 Free PMC article. Clinical Trial.
227 results